Nagarro Named Leader in 2024 Life Sciences Digital Services by Everest Group, Strengthening Its Position in Digital Transformation

Nagarro Named Leader in 2024 Life Sciences Digital Services by Everest Group, Strengthening Its Position in Digital Transformation

(IN BRIEF) Nagarro has been recognized as a Leader in the Everest Group’s 2024 Life Sciences Digital Services for Mid-market Enterprises PEAK Matrix® Assessment. This recognition highlights Nagarro’s innovation, client-centric approach, and significant investments in advanced technologies such as AI/ML and IoT. Nagarro continues to solidify its role as a trusted digital transformation partner for the life sciences sector.

(PRESS RELEASE) MUNICH, 14-Aug-2024 — /EuropaWire/ — Nagarro, a global leader in digital engineering, has been recognized as a Leader in the Everest Group’s 2024 Life Sciences Digital Services for Mid-market Enterprises PEAK Matrix® Assessment. This prestigious recognition highlights Nagarro’s strategic vision and solidifies its reputation as a trusted partner for life sciences companies seeking to leverage digital transformation for innovation and growth.

Andrei Doibani, Global Business Unit Head for Life Sciences and Healthcare at Nagarro, expressed the company’s ongoing commitment to the sector: “Nagarro remains dedicated to driving excellence in digital services for the Life Sciences and Healthcare sectors. We will continue to invest in our capabilities, refine our offerings, and position ourselves as a valuable digital transformation partner for this industry.”

The Everest Group’s assessment underscores Nagarro’s innovation, quality, and customer-centric approach within the rapidly evolving life sciences industry.

The report highlights several key strengths that contributed to Nagarro’s Leader status:

  • Innovative Technology Solutions: Nagarro’s robust portfolio includes advanced digital services such as AI/ML applications in drug discovery, blockchain for secure data management, and IoT solutions for real-time monitoring of medical devices. These technologies enable Nagarro to provide personalized, proactive support that keeps its clients agile and resilient.
  • Client-Centric Approach: The report commends Nagarro’s deep understanding of the unique challenges faced by mid-market life sciences enterprises, such as regulatory complexities and the optimization of clinical trial processes. Nagarro’s focus on building trust-based client relationships has been a key factor in its success.
  • Investment in Expertise and Innovation: Nagarro’s long-term vision and commitment to innovation are evident in its creation of Centers of Excellence (CoEs) that foster the adoption of advanced technologies, including Generative AI.

For those interested in the full assessment report, it is available for download at Nagarro’s website.

About Everest Group

Everest Group is a leading research firm helping business leaders make confident decisions. We guide clients through today’s market challenges and strengthen their strategies by applying contextualized problem-solving to their unique situations. This drives maximized operational and financial performance and transformative experiences. Our deep expertise and tenacious research focused on technology, business processes, and engineering through the lenses of talent, sustainability, and sourcing delivers precise and action-oriented guidance. Find further details and in-depth content at www.everestgrp.com.

About Nagarro

Nagarro, a global digital engineering leader, helps clients become fluidic, innovative, digital-first companies and thus, win in their markets. The company is distinguished by its entrepreneurial, agile, and global character, its CARING mindset, and its Fluidic Enterprise vision. Nagarro employs over 18,000 people in 36 countries. For more information, For more information, visit www.nagarro.com.

FRA: NA9 (SDAX/TecDAX, ISIN DE000A3H2200, WKN A3H220)

Media Contact:

press@nagarro.com.

SOURCE: Nagarro

Follow EuropaWire on Google News
EDITOR'S PICK:

Comments are closed.